Insulin prices have rising — increases that mean some people are spending as much on monthly diabetes-related expenses as their mortgage payment.
As a result, the companies that make insulin have been under fire from the public and...
BEIJING (dpa-AFX) - New Oriental Education and Technology Group Inc. (EDU),
a provider of private educational services in China,responded to recent media
reports referencing its small overseas study consulting division, New Oriental
After a tough year, shares of Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) have managed to rebound more than 29 percent in the last month, largely on the back of the announcement that the FDA had allowed it to pursue regulatory approval of its...
Novo Nordisk said its new insulin Tresiba carries about the same risk of serious heart problems as Sanofi’s Lantus but offers significantly lower risk of dangerously low blood sugar in people with Type-2 diabetes.
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Novo Nordisk A/S (NVO):